Placebo: Clinical Trials

43,906 trials of Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28157 completed, 4046 terminated, 3771 unknown, 3427 recruiting. 15207 Phase 2, 10901 Phase 3, 8516 Phase 1, 7335 Not applicable, 4459 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 215207Completed 9271, Terminated 1805, Recruiting 1264, Unknown 1099, Withdrawn 671, Active not recruiting 546, Not yet recruiting 463, Suspended 50, Enrolling by invitation 38
Phase 310901Completed 6785, Terminated 1156, Recruiting 928, Unknown 802, Active not recruiting 562, Withdrawn 333, Not yet recruiting 287, Suspended 28, Enrolling by invitation 20
Phase 18516Completed 6179, Terminated 644, Recruiting 594, Unknown 411, Withdrawn 240, Not yet recruiting 221, Active not recruiting 193, Suspended 21, Enrolling by invitation 13
Not applicable7335Completed 4597, Unknown 1106, Recruiting 567, Not yet recruiting 338, Terminated 308, Withdrawn 197, Active not recruiting 154, Enrolling by invitation 51, Suspended 17
Phase 44459Completed 2738, Unknown 629, Terminated 431, Recruiting 281, Withdrawn 162, Not yet recruiting 133, Active not recruiting 69, Suspended 9, Enrolling by invitation 7
Early Phase 1618Completed 353, Recruiting 80, Unknown 70, Not yet recruiting 32, Terminated 28, Active not recruiting 23, Withdrawn 22, Enrolling by invitation 6, Suspended 4

Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of CZ10 in Healthy Volunteers
Contrast Media, Placebo - Healthy Volunteer Study
Phase 1Not yet recruitingNextrast, Inc.242050-01-012024-11-29
Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
Cannabidiol (CBD), Placebo - Schizophrenia Spectrum Disorders, Cannabis Use
Phase 2WithdrawnUniversity of Maryland, Baltimore2050-01-012021-04-19
Influence of Fampridine on Working Memory in Healthy Subjects
Fampridine SR, Placebo - Working Memory
Phase 2WithdrawnProf. Dominique de Quervain, MD2040-01-012024-12-05
Evaluation of Naloxegol in the Prevention of POI After Cystectomy
Naloxégol oxalate, Placebo oral tablet - Bladder Cancer, Cystostomy; Complications
Phase 2WithdrawnInstitut Paoli-Calmettes2032-01-012026-10-14
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance
Phase 2WithdrawnUniversity of Arizona2030-04-152025-07-30
Effect of Propionic Acid Supplementation on Endothelial Function
Sodium Propionate, Placebo - Cardiovascular Diseases, Endothelial Dysfunction
Not applicableNot yet recruitingMedical College of Wisconsin202029-07-012026-10-30
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
Terazosin And Metabolic Energetics in Parkinson's Disease
Terazosin 5 MG, Placebo - Parkinson's Disease (PD)
Phase 2SuspendedErgun Y. Uc1202028-07-012026-10-09
Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells, Placebo - Spinal Cord Injury, Safety
Phase 2Not yet recruitingXellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.602028-05-252025-11-25
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)
Trazodone, Quetiapine, Placebo - Delirium, Morality
Phase 4WithdrawnUniversity of Southern California2028-03-012026-05-04
Pyronaridine in Acute Myeloid Leukemia (AML)
Pyronaridine Tetraphosphate - Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL)
Phase 2SuspendedArmaceutica, Inc.2002028-02-212026-10-19
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders
Ginger, Placebo - Women With Coagulation Disorders
Early Phase 1Not yet recruitingUniversity of Valladolid742028-02-012026-05-19
Sodium Lactate in Severe TBI
Sodium Lactate, placebo - Traumatic Brain Injury
Phase 2Not yet recruitingUniversity of California, Los Angeles2642028-01-102026-01-16
Effects of Food Intake on Biomarker Activity in Normal Humans Taking Immulina
Immulina, Placebo - Viral Diseases
Phase 2Not yet recruitingUniversity of Mississippi Medical Center2502028-01-012026-10-23
Perioperative Esketamine Safety and Efficacy in Reducing Postoperative ENDometriosis PAIN (the ENDPAIN Trial): a Randomized Controlled Trial.
Esketamine, Placebo - Endometriosis
Phase 4Not yet recruitingRegion Skane10002028-01-012026-10-19
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Gemfibrozil, Placebo - Parkinson Disease
Phase 2WithdrawnForest Hills Lab2027-11-012026-08-19
The Effects of Menopausal Status, Isoflavone Supplementation and Training on Cardiometabolic Function Women
Red Clover Isoflavone Supplementation, Supervised exercise training, Placebo Supplementation - Menopause, Exercise Adaptation
Not applicableNot yet recruitingUniversity of Copenhagen602027-10-152026-10-16
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
DA-007, Placebo - Chemotherapy Induced Alopecia, Chemotherapy Side Effects
Phase 3Not yet recruitingApplied Biology, Inc.1402027-10-102026-11-02

Showing 20 of 43906. Sign in to see all of them.

Conditions studied

Diabetes Mellitus, Type 2 (1513)  ·  Obesity (1266)  ·  COVID-19 (901)  ·  Pain (851)  ·  Diabetes Mellitus (753)  ·  Asthma (678)  ·  Alzheimer Disease (662)  ·  Pulmonary Disease, Chronic Obstructive (638)  ·  Inflammation (611)  ·  Depression (601)  ·  Schizophrenia (570)  ·  Overweight (544)  ·  Depressive Disorder, Major (543)  ·  Arthritis, Rheumatoid (496)  ·  Parkinson Disease (468)

Sponsors

Eli Lilly and Company (775)  ·  GlaxoSmithKline (736)  ·  Pfizer (722)  ·  AstraZeneca (714)  ·  Boehringer Ingelheim (560)  ·  Novartis Pharmaceuticals (554)  ·  Hoffmann-La Roche (381)  ·  Merck Sharp & Dohme LLC (356)  ·  Sanofi (297)  ·  Amgen (295)  ·  Janssen Research & Development, LLC (294)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (292)  ·  Bayer (267)  ·  Novo Nordisk A/S (258)  ·  Yale University (244)

Countries

United States (20189)  ·  Germany (4902)  ·  Canada (4894)  ·  United Kingdom (4610)  ·  Spain (3925)  ·  China (3735)  ·  France (3696)  ·  Poland (3302)  ·  Italy (3301)  ·  Australia (2965)  ·  Belgium (2527)  ·  Netherlands (2435)  ·  South Korea (2427)  ·  Japan (2335)  ·  Czechia (2015)

Results publications

PMID 34473343, PMID 37142273, PMID 33687069, PMID 37811711, PMID 38770818, PMID 39356039, PMID 40576086, PMID 32816215, PMID 36005278, PMID 37160401, PMID 25019647, PMID 36526796, PMID 36931693, PMID 39963952, PMID 37230961, PMID 38299639, PMID 35713300, PMID 33283264, PMID 34870800, PMID 36600185, PMID 36601090, PMID 37185961, PMID 28433500, PMID 33127856, PMID 37316690, PMID 37983082, PMID 38767196, PMID 39192350, PMID 28143815, PMID 31606880, PMID 33107592, PMID 33331662, PMID 34611902, PMID 35141873, PMID 37916745, PMID 40603145, PMID 25047021, PMID 31903692, PMID 32734597, PMID 35472672, PMID 38958913, PMID 32998732, PMID 34510411, PMID 35224730, PMID 36375174, PMID 26275429, PMID 33710614, PMID 38979716, PMID 39393433, PMID 40680102

NIH funding

2023 (475), 2017 (365), 2015 (359), 2014 (344), 2018 (332), 2016 (327), 2025 (305), 2019 (281), 2009 (272), 2008 (221), 2005 (71), 2004 (44), UL1RR024150 (28), P30CA015083 (20), P30CA016672 (14)